| scholarly article | Q13442814 |
| P2093 | author name string | Ana Paula Galvão Da Silva | |
| Ises De Almeida Abrahamsohn | |||
| Jacqueline F Jacysyn | |||
| P2860 | cites work | Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | Q24290619 |
| Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection | Q28365242 | ||
| Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi | Q34003863 | ||
| Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis | Q34431001 | ||
| Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro | Q34546031 | ||
| Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages | Q35457307 | ||
| Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes | Q35494931 | ||
| Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. | Q35501871 | ||
| Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection | Q35750253 | ||
| Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist | Q36260899 | ||
| Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection | Q39419338 | ||
| Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase | Q39570411 | ||
| Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice | Q39571751 | ||
| Regulation of nitric oxide synthesis in infectious and autoimmune diseases | Q40517670 | ||
| Mechanism and regulation of immunoglobulin isotype switching. | Q40850235 | ||
| The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta | Q41600919 | ||
| Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages | Q41640032 | ||
| Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism | Q41641701 | ||
| Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection | Q41746672 | ||
| Modulation induced by estradiol in the acute phase of Trypanosoma cruzi infection in mice | Q43695103 | ||
| Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi | Q44684713 | ||
| In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting | Q45069275 | ||
| Influence of female gonadal hormones on the parasitemia of female Calomys callosus infected with the "Y" strain of Trypanosoma cruzi | Q50904202 | ||
| Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. | Q52520769 | ||
| Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. | Q52522603 | ||
| Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. | Q52937076 | ||
| NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation. | Q53973062 | ||
| IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. | Q53994536 | ||
| Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. | Q54296214 | ||
| Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection | Q58842426 | ||
| Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection | Q58843389 | ||
| Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection | Q58843603 | ||
| IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi | Q58845286 | ||
| Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi | Q58846768 | ||
| Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis | Q58846788 | ||
| Interleukin-12: a cytokine at the interface of inflammation and immunity | Q77355814 | ||
| P433 | issue | 2 | |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 230-237 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response | |
| P478 | volume | 108 |
| Q33760119 | A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease |
| Q59800419 | Arginase-1 Is Responsible for IL-13-Mediated Susceptibility to Trypanosoma cruzi Infection |
| Q27319499 | Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses |
| Q37310959 | Chagas' disease: an update on immune mechanisms and therapeutic strategies |
| Q37582794 | Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived en |
| Q38927945 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation |
| Q37754742 | Gene expression patterns and susceptibility to allergic responses. |
| Q37426304 | Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains |
| Q33282864 | Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load |
| Q33483331 | NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection |
| Q35758872 | The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole |
| Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
| Q35126647 | The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease. |
| Q46009587 | Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. |
Search more.